aamc.org does not support this web browser. Learn more about the browsers we support.

New section

Content Background

New section

CMS Issues Code for Remdesivir Outpatient Administration

January 7, 2022

New section

New section

CONTACTS
Mary Mullaney, Director, Hospital Payment Policies

The Centers for Medicare & Medicaid Services (CMS) issued a new Healthcare Common Procedure Coding System (HCPCS) code for the antiviral medication VEKLURYTM (remdesivir) when administered in the outpatient setting in a Jan. 7 announcement. The new code is in response to the recent statement from the National Institutes of Health COVID-19 Treatment guidelines regarding therapies for the Omicron variant of COVID-19.

The CMS noted that because Medicare Administrative Contractors (MACs) determine Medicare coverage when there is no national coverage determination, including in cases when providers use Food and Drug Administration (FDA)-approved drugs for indications other than what is on the approved label, they will determine Medicare coverage for HCPCS code J0248 for VEKLURY™ (remdesivir) administered in an outpatient setting. The announcement concluded that MACs would share coverage and claims processing information for J0248.

New section

New section